-
1
-
-
79551706922
-
-
OECD Publishing Paris, France.
-
Sassi, F., M. Devaux, M. Cecchini, and E. Rusticelli. 2009. The obesity epidemic: analysis of past and projected future trends in selected OECD countries. OECD Publishing Paris, France.
-
(2009)
The obesity epidemic: analysis of past and projected future trends in selected OECD countries
-
-
Sassi, F.1
Devaux, M.2
Cecchini, M.3
Rusticelli, E.4
-
2
-
-
33751373088
-
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer
-
Dignam, J. J., B. N. Polite, G. Yothers, P. Raich, L. Colangelo, M. J. O'Connell, et al. 2006. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J. Natl. Cancer Inst. 98:1647-1654.
-
(2006)
J. Natl. Cancer Inst.
, vol.98
, pp. 1647-1654
-
-
Dignam, J.J.1
Polite, B.N.2
Yothers, G.3
Raich, P.4
Colangelo, L.5
O'Connell, M.J.6
-
3
-
-
38949108241
-
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
-
Renehan, A. G., M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen. 2008. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578.
-
(2008)
Lancet
, vol.371
, pp. 569-578
-
-
Renehan, A.G.1
Tyson, M.2
Egger, M.3
Heller, R.F.4
Zwahlen, M.5
-
4
-
-
77949697892
-
Obesity is an independent prognostic variable in colon cancer survivors
-
Sinicrope, F. A., N. R. Foster, D. J. Sargent, M. J. O'Connell, and C. Rankin. 2010. Obesity is an independent prognostic variable in colon cancer survivors. Clin. Cancer Res. 16:1884-1893.
-
(2010)
Clin. Cancer Res.
, vol.16
, pp. 1884-1893
-
-
Sinicrope, F.A.1
Foster, N.R.2
Sargent, D.J.3
O'Connell, M.J.4
Rankin, C.5
-
5
-
-
0037962010
-
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma
-
Meyerhardt, J. A., P. J. Catalano, D. G. Haller, R. J. Mayer, A. B. Benson, III, J. S. Macdonald, et al. 2003. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98:484-495.
-
(2003)
Cancer
, vol.98
, pp. 484-495
-
-
Meyerhardt, J.A.1
Catalano, P.J.2
Haller, D.G.3
Mayer, R.J.4
Benson, A.B.5
Macdonald, J.S.6
-
6
-
-
0037464510
-
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
-
Calle, E. E., C. Rodriguez, K. Walker-Thurmond, and M. J. Thun. 2003. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348:1625-1638.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 1625-1638
-
-
Calle, E.E.1
Rodriguez, C.2
Walker-Thurmond, K.3
Thun, M.J.4
-
7
-
-
42549136991
-
Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells
-
Fenton, J. I., J. M. Birmingham, S. D. Hursting, and N. G. Hord. 2008. Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells. Int. J. Cancer 122:2437-2445.
-
(2008)
Int. J. Cancer
, vol.122
, pp. 2437-2445
-
-
Fenton, J.I.1
Birmingham, J.M.2
Hursting, S.D.3
Hord, N.G.4
-
8
-
-
54349120590
-
Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition
-
Fujisawa, T., H. Endo, A. Tomimoto, M. Sugiyama, H. Takahashi, S. Saito, et al. 2008. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 57:1531-1538.
-
(2008)
Gut
, vol.57
, pp. 1531-1538
-
-
Fujisawa, T.1
Endo, H.2
Tomimoto, A.3
Sugiyama, M.4
Takahashi, H.5
Saito, S.6
-
9
-
-
3543072186
-
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
-
Calle, E. E., and R. Kaaks. 2004. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4:579-591.
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 579-591
-
-
Calle, E.E.1
Kaaks, R.2
-
10
-
-
64349089491
-
Novel mechanism for obesity-induced colon cancer progression
-
Birmingham, J. M., J. V. Busik, F. M. Hansen-Smith, and J. I. Fenton. 2009. Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis 30:690-697.
-
(2009)
Carcinogenesis
, vol.30
, pp. 690-697
-
-
Birmingham, J.M.1
Busik, J.V.2
Hansen-Smith, F.M.3
Fenton, J.I.4
-
11
-
-
80755128127
-
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy
-
Simkens, L. H., M. Koopman, L. Mol, G. J. Veldhuis, D. Ten Bokkel Huinink, E. W. Muller, et al. 2011. Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. Eur. J. Cancer 47:2560-2567.
-
(2011)
Eur. J. Cancer
, vol.47
, pp. 2560-2567
-
-
Simkens, L.H.1
Koopman, M.2
Mol, L.3
Veldhuis, G.J.4
Ten Bokkel Huinink, D.5
Muller, E.W.6
-
12
-
-
77749306533
-
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer
-
Guiu, B., J. M. Petit, F. Bonnetain, S. Ladoire, S. Guiu, J. P. Cercueil, et al. 2010. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut 59:341-347.
-
(2010)
Gut
, vol.59
, pp. 341-347
-
-
Guiu, B.1
Petit, J.M.2
Bonnetain, F.3
Ladoire, S.4
Guiu, S.5
Cercueil, J.P.6
-
13
-
-
78650396059
-
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)-results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
-
Asmis, T. R., E. Powell, C. S. Karapetis, D. J. Jonker, D. Tu, M. Jeffery, et al. 2011. Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)-results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care. Ann. Oncol. 22:118-126.
-
(2011)
Ann. Oncol.
, vol.22
, pp. 118-126
-
-
Asmis, T.R.1
Powell, E.2
Karapetis, C.S.3
Jonker, D.J.4
Tu, D.5
Jeffery, M.6
-
14
-
-
73249136662
-
Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases
-
Pathak, S., J. M. Tang, M. Terlizzo, G. J. Poston, and H. Z. Malik. 2010. Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases. Eur. J. Surg. Oncol. 36:52-57.
-
(2010)
Eur. J. Surg. Oncol.
, vol.36
, pp. 52-57
-
-
Pathak, S.1
Tang, J.M.2
Terlizzo, M.3
Poston, G.J.4
Malik, H.Z.5
-
15
-
-
84899108371
-
Excess adiposity and survival in patients with colorectal cancer: a systematic review
-
Parkin, E., D. A. O'Reilly, D. J. Sherlock, P. Manoharan, and A. G. Renehan. 2014. Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes. Rev. 15:434-451.
-
(2014)
Obes. Rev.
, vol.15
, pp. 434-451
-
-
Parkin, E.1
O'Reilly, D.A.2
Sherlock, D.J.3
Manoharan, P.4
Renehan, A.G.5
-
16
-
-
79955153377
-
South Australian clinical registry for metastatic colorectal cancer
-
Neo, E. L., C. Beeke, T. Price, G. Maddern, C. Karapetis, C. Luke, et al. 2011. South Australian clinical registry for metastatic colorectal cancer. ANZ. J. Surg. 81:352-357.
-
(2011)
ANZ. J. Surg.
, vol.81
, pp. 352-357
-
-
Neo, E.L.1
Beeke, C.2
Price, T.3
Maddern, G.4
Karapetis, C.5
Luke, C.6
-
17
-
-
0003588157
-
Physical status: the use and interpretation of anthropometry
-
Report of a WHO expert committee. Technical Report Series No. 854. World Health Organization.
-
WHO. 1995. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. Technical Report Series No. 854. World Health Organization.
-
(1995)
-
-
-
20
-
-
84862262378
-
Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy
-
Parsons, H. A., A. M. Tsimberidou, M. Pontikos, S. Fu, D. Hong, S. Wen, et al. 2012. Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy. Nutr. Cancer 64:206-217.
-
(2012)
Nutr. Cancer
, vol.64
, pp. 206-217
-
-
Parsons, H.A.1
Tsimberidou, A.M.2
Pontikos, M.3
Fu, S.4
Hong, D.5
Wen, S.6
-
21
-
-
84858071707
-
Body composition and outcome in patients undergoing resection of colorectal liver metastases
-
van Vledder, M. G., S. Levolger, N. Ayez, C. Verhoef, T. C. Tran, and J. N. Ijzermans. 2012. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br. J. Surg. 99:550-557.
-
(2012)
Br. J. Surg.
, vol.99
, pp. 550-557
-
-
van Vledder, M.G.1
Levolger, S.2
Ayez, N.3
Verhoef, C.4
Tran, T.C.5
Ijzermans, J.N.6
-
22
-
-
33847705337
-
Gender differences in colorectal cancer: implications for age at initiation of screening
-
Brenner, H., M. Hoffmeister, V. Arndt, and U. Haug. 2007. Gender differences in colorectal cancer: implications for age at initiation of screening. Br. J. Cancer 96:828-831.
-
(2007)
Br. J. Cancer
, vol.96
, pp. 828-831
-
-
Brenner, H.1
Hoffmeister, M.2
Arndt, V.3
Haug, U.4
-
23
-
-
84880949229
-
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy
-
Faruk Aykan, N., I. Yildiz, F. Sen, L. Kilic, S. Keskin, R. Ciftci, et al. 2013. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy. Med. Oncol. 30:679.
-
(2013)
Med. Oncol.
, vol.30
, pp. 679
-
-
Faruk Aykan, N.1
Yildiz, I.2
Sen, F.3
Kilic, L.4
Keskin, S.5
Ciftci, R.6
-
24
-
-
84925486404
-
Bevacizumab for metastatic colon cancer: does patient BMI influence survival?
-
Kaidar-Person, O., H. Badarna, and G. Bar-Sela. 2015. Bevacizumab for metastatic colon cancer: does patient BMI influence survival? Anticancer Drugs 26:363-366.
-
(2015)
Anticancer Drugs
, vol.26
, pp. 363-366
-
-
Kaidar-Person, O.1
Badarna, H.2
Bar-Sela, G.3
-
25
-
-
84862986506
-
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline
-
Griggs, J. J., P. B. Mangu, H. Anderson, E. P. Balaban, J. J. Dignam, W. M. Hryniuk, et al. 2012. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol. 30:1553-1561.
-
(2012)
J. Clin. Oncol.
, vol.30
, pp. 1553-1561
-
-
Griggs, J.J.1
Mangu, P.B.2
Anderson, H.3
Balaban, E.P.4
Dignam, J.J.5
Hryniuk, W.M.6
-
26
-
-
84887409824
-
Appropriate chemotherapy dosing in obese patients with cancer
-
Lyman, G. H., and A. Sparreboom. 2013. Appropriate chemotherapy dosing in obese patients with cancer. Nat. Rev. Clin. Oncol. 10:664.
-
(2013)
Nat. Rev. Clin. Oncol.
, vol.10
, pp. 664
-
-
Lyman, G.H.1
Sparreboom, A.2
-
27
-
-
84882932432
-
Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial
-
Hawkes, A. L., S. K. Chambers, K. I. Pakenham, T. A. Patrao, P. D. Baade, B. M. Lynch, et al. 2013. Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial. J. Clin. Oncol. 31:2313-2321.
-
(2013)
J. Clin. Oncol.
, vol.31
, pp. 2313-2321
-
-
Hawkes, A.L.1
Chambers, S.K.2
Pakenham, K.I.3
Patrao, T.A.4
Baade, P.D.5
Lynch, B.M.6
-
28
-
-
84896960276
-
A randomized pilot study with daily walking during adjuvant chemotherapy for patients with breast and colorectal cancer
-
Backman, M., Y. Wengström, B. Johansson, I. Sköldengen, S. Börjesson, S. Tärnbro, et al. 2014. A randomized pilot study with daily walking during adjuvant chemotherapy for patients with breast and colorectal cancer. Acta Oncol. 53:510-520.
-
(2014)
Acta Oncol.
, vol.53
, pp. 510-520
-
-
Backman, M.1
Wengström, Y.2
Johansson, B.3
Sköldengen, I.4
Börjesson, S.5
Tärnbro, S.6
|